Eliquis is not typically classified as a specialty drug. It is an oral tablet stored at room temperature, dispensed at regular pharmacies, and does not require the special handling, injection, or clinical monitoring that define most specialty medications. However, its high list price and insurance tier placement can make it feel like one from a cost perspective.
What Makes a Drug “Specialty”
The term “specialty drug” generally refers to medications that require special storage (like refrigeration), administration by injection or infusion, close clinical monitoring, or restricted distribution through specialty pharmacies. Think of biologics for autoimmune diseases or cancer therapies that need cold-chain shipping and nurse supervision. These drugs are typically placed on the highest insurance tier, often called the “specialty tier.”
Eliquis doesn’t fit this profile. It’s a standard oral tablet stored at room temperature (68°F to 77°F). It doesn’t require routine blood monitoring to adjust the dose, which is actually one of its advantages over older blood thinners like warfarin. And it’s available at any retail pharmacy. The CVS Specialty drug list, one of the largest specialty pharmacy catalogs in the country, does not include Eliquis.
Why Eliquis Feels Expensive Like a Specialty Drug
The confusion is understandable. Eliquis has a list price of $606 per month in 2025, which is dramatically higher than older alternatives. Warfarin, the blood thinner it often replaces, costs roughly $13 to $14 for a 100-tablet supply without insurance. That’s a difference of more than 40 to 1 on a per-pill basis ($5.76 per Eliquis tablet versus about $0.14 for warfarin).
For Medicare Part D, a drug qualifies for the specialty tier when its 30-day ingredient cost exceeds $950 (the threshold for 2024). Eliquis falls below that ceiling at its list price of $606, so most Medicare plans place it on Tier 3 or Tier 4 rather than the specialty tier. During a 2023 CMS listening session on Medicare drug pricing, the majority of plans were charging patients 16% to 25% of the drug’s cost through these mid-to-upper tiers. That can still translate to a meaningful monthly bill, especially for people on fixed incomes.
How Insurance Plans Typically Cover Eliquis
On most commercial and Medicare formularies, Eliquis lands on a preferred or non-preferred brand-name tier. Tier 3 usually means a fixed copay or moderate coinsurance. Tier 4 (sometimes called “non-preferred brand”) typically means higher coinsurance, often in the range of 25% to 50% of the drug’s cost. Your actual out-of-pocket amount depends on your specific plan design.
Because Eliquis is not classified as specialty, you won’t be required to fill it through a specialty pharmacy or deal with prior authorization in most cases, though some plans do require step therapy or prior authorization for newer blood thinners regardless of tier.
Lowering Your Out-of-Pocket Cost
Bristol Myers Squibb and Pfizer offer a copay assistance program for commercially insured patients. The program covers up to $2,000 per year toward your out-of-pocket costs. To qualify, you need to have commercial insurance with a copay obligation for Eliquis and cannot be enrolled in any government program, including Medicare Part D, Medicaid, TRICARE, or VA coverage.
For cash-paying patients without insurance, the manufacturers also offer a direct-to-consumer price of $346 per month, a 43% discount off the $606 list price. That lower price is still considerably more expensive than warfarin, but it brings the cost closer to what many insured patients pay after their plan’s discount.
Eliquis was also selected for Medicare’s drug price negotiation program, which means a government-negotiated price will apply to Medicare Part D enrollees in the coming years, potentially reducing costs further for that population.
The Bottom Line on Classification
By every standard industry definition, Eliquis is a traditional brand-name drug, not a specialty drug. It doesn’t require special pharmacies, cold storage, injections, or regular lab monitoring. Its cost is high for an oral medication, which is why insurers place it on upper brand-name tiers, but it consistently falls below the specialty tier threshold. If your plan is routing you through a specialty pharmacy or charging specialty-tier pricing for Eliquis, it’s worth calling your insurer to verify your tier placement and ask about alternatives or appeals.